1. Home
  2. AMPH vs ECPG Comparison

AMPH vs ECPG Comparison

Compare AMPH & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ECPG
  • Stock Information
  • Founded
  • AMPH 1996
  • ECPG 1998
  • Country
  • AMPH United States
  • ECPG United States
  • Employees
  • AMPH N/A
  • ECPG N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ECPG Finance Companies
  • Sector
  • AMPH Health Care
  • ECPG Finance
  • Exchange
  • AMPH Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • AMPH 1.3B
  • ECPG 1.2B
  • IPO Year
  • AMPH 2014
  • ECPG 1999
  • Fundamental
  • Price
  • AMPH $28.29
  • ECPG $35.16
  • Analyst Decision
  • AMPH Hold
  • ECPG Strong Buy
  • Analyst Count
  • AMPH 3
  • ECPG 3
  • Target Price
  • AMPH $43.50
  • ECPG $62.67
  • AVG Volume (30 Days)
  • AMPH 569.1K
  • ECPG 323.0K
  • Earning Date
  • AMPH 05-07-2025
  • ECPG 05-07-2025
  • Dividend Yield
  • AMPH N/A
  • ECPG N/A
  • EPS Growth
  • AMPH 17.69
  • ECPG N/A
  • EPS
  • AMPH 3.06
  • ECPG N/A
  • Revenue
  • AMPH $731,967,000.00
  • ECPG $1,316,361,000.00
  • Revenue This Year
  • AMPH $2.60
  • ECPG $21.62
  • Revenue Next Year
  • AMPH $9.42
  • ECPG $10.12
  • P/E Ratio
  • AMPH $9.25
  • ECPG N/A
  • Revenue Growth
  • AMPH 13.59
  • ECPG 7.66
  • 52 Week Low
  • AMPH $25.89
  • ECPG $31.54
  • 52 Week High
  • AMPH $53.96
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 43.50
  • ECPG 41.28
  • Support Level
  • AMPH $28.01
  • ECPG $33.55
  • Resistance Level
  • AMPH $29.18
  • ECPG $36.68
  • Average True Range (ATR)
  • AMPH 0.79
  • ECPG 1.37
  • MACD
  • AMPH 0.35
  • ECPG 0.59
  • Stochastic Oscillator
  • AMPH 72.95
  • ECPG 70.43

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchase portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumer repay their obligations and work toward financial recovery. Encore has only a reportable segment being portfolio purchasing and recovery.

Share on Social Networks: